ContraFect Reports Third Quarter 2019 Financial Results and Provides Business Update

    NEXT STORY
    Forty Seven, Inc. Reports Third Quarter 2019 Financial Results and Recent Business Highlights
    PREV STORY
    BriaCell to Present Clinical Findings at the 2019 San Antonio Breast Cancer Symposium® December 12th and 13th
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    New Imaging Suite at NYC Health + Hospitals/Coney Island Presents a Bright Picture of Enhanced Patient Care

    Brooklyn, New York, Aug. 23, 2018 (GLOBE NEWSWIRE) -- (Brooklyn, NY – August 22, ...

    author_avatar
    NASDAQ Market News

    Calithera to Participate in Multiple Upcoming Investor Conferences

    author_avatar
    NASDAQ Market News

    TESARO Announces Availability of VARUBI® (rolapitant) IV for Delayed Nausea and Vomiting Associated With Cancer Chemotherapy in the United States

    VARUBI injectable emulsion features ready-to-use, single-dose vialNo saline, reconstitution or mixing is required to ...

    author_avatar
    NASDAQ Market News